Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis is a research paper published in Proceedings of the National Academy of Sciences (2017). On theSindex it has a DataRank of 0.935. It has been cited 508 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.935
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Prevention and Research Institute of Texas
Grant: RP130145
U.S. Department of Defense
Grant: W81XWH-13-1-0318
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK089113
Mary Kay Foundation
Grant: #073.14
Welch Foundation
Grant: I-1751
HHS | NIH | National Cancer Institute
Grant: 5P30CA142543
Cancer Prevention and Research Institute of Texas
Grant: R1212
Welch Foundation
Grant: I-1855
NCI NIH HHS
Grant: P30 CA014195
NIGMS NIH HHS
Grant: T32 GM007198
NCI NIH HHS
Grant: P30 CA142543
MeSH Terms
Keywords
Additional file 1 of Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
Additional file 1 of Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway
Additional file 1 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 1 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 2 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 2 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 3 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 3 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 4 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 4 of Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development
Additional file 1 of GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression
Additional file 1 of GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression
Additional file 1 of Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway
Additional file 1 of Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway